Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Citroflex 2

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7BUDESONIDE

    02 1CREON

    03 1DEXILANT

    04 3DIMETHYL FUMARATE

    05 1ENTOCORT EC

    06 2ESOMEPRAZOLE MAGNESIUM

    07 1ESOMEPRAZOLE STRONTIUM

    08 7FENOFIBRIC ACID

    09 1NEXIUM 24HR

    10 1OMEPRAZOLE MAGNESIUM

    11 1ORTIKOS

    12 1PANCREAZE

    13 1PROCYSBI

    14 1ZENPEP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)

    Drug : CREON

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 20725

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DR REDDYS LABS SA
    India
    arrow
    MAGHREB Pharma Expo
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 206623

    Country : US

    Patented : No

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ACCORD HLTHCARE

    DIMETHYL FUMARATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    ACCORD HLTHCARE
    United Kingdom
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210499

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    HORIZON

    CYSTEAMINE BITARTRATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    HORIZON
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CYSTEAMINE BITARTRATE

    Drug : PROCYSBI

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 203389

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    EURAND PHARMA LTD

    PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)

    arrow
    Health 2.0 Conference
    Not Confirmed
    EURAND PHARMA LTD
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)

    Drug : ZENPEP

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 22210

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    GLENMARK PHARMS LTD

    DIMETHYL FUMARATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210309

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    RISING

    CHOLINE FENOFIBRATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    RISING
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 211626

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    RISING

    BUDESONIDE

    arrow
    Health 2.0 Conference
    Not Confirmed
    RISING
    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BUDESONIDE

    Drug : BUDESONIDE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 207367

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    PH HEALTH

    CHOLINE FENOFIBRATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    PH HEALTH
    Country
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 201573

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    PHARMOBEDIENT

    CHOLINE FENOFIBRATE

    arrow
    Health 2.0 Conference
    Not Confirmed
    PHARMOBEDIENT
    Country
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CHOLINE FENOFIBRATE

    Drug : FENOFIBRIC ACID

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 200913

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.